Ajax and Cameroon Goalkeeper Andre Onana Banned One Year for Doping Violation

Ajax goalkeeper Andre Onana, linked with Chelsea and Borussia Dortmund recently, has been banned from football for a year for a doping violation.

The Dutch giants, however, say they’ll appeal.

The 24-year-old Cameroon international failed an out-of-competition drugs test in October when the banned substance furosemide was found in his urine sample.

Ajax said Onana had mistakenly taken medication prescribed for his wife while feeling unwell.

The club and Onana will appeal to the Court of Arbitration for Sport against the suspension, imposed by Uefa.

In a statement on social media, Onana said he had mistaken his wife’s medicine for aspirin because the packaging was “almost identical” and called his ban “excessive and disproportionate”.

“Everything was the result of a human mistake,” he said.

“Everyone knows that I lead a very healthy life, and since I started my sporting career, I have always been strongly against any use of doping and I condemn any unsportsmanlike conduct.

“I have no need to resort to doping to further enhance my sporting career.”

Ajax said in a statement that Uefa had agreed Onana had not intentionally cheated but that the governing body believed “an athlete has a duty at all times to ensure that no banned substances enter the body”.

Onana, who has 18 caps for Cameroon, will miss the delayed 2021 Africa Cup of Nations. Cameroon are the host nation for the tournament, which has been rearranged for January 2022.

Ajax managing director Edwin van der Sar said: “We explicitly renounce performance-enhancing drugs – we obviously stand for a clean sport.

“This is a terrible setback, for Andre himself but certainly also for us as a club. Andre is a top goalkeeper, who has proven his worth for Ajax for years and is very popular with the fans.

“We had hoped for a conditional suspension or for a suspension much shorter than these 12 months because it was arguably not intended to strengthen his body and thus improve his performance.”

Follow us on: